Insider Trading activities of Progenics Pharmaceuticals Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Progenics Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Progenics Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Progenics Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is PGNX. The reporting company's CIK number is 835887.
The total value of stock buying since 2005 is $8,030,657.
The total value of stock sales since 2005 is $30,175,090.
The total value of stock option exercises since 2005 is $9,042,404.


Go to page:  1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Progenics Pharmaceuticals Inc insiders (PGNX) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-03-18 Baker Mark Robert (President) Sale 2,165 5.33 11,539
2010-03-18 Israel Robert J (Sr. VP, Medical Affairs) Sale 7,056 5.37 37,890
2010-01-04 Baker Mark Robert (General Counsel) Option Ex 4,720 3.78 17,855
2010-01-04 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 3,147 3.78 11,905
2010-01-04 Olson William C (VP, Research & Development) Option Ex 2,989 3.78 11,307
2010-01-04 Mckinney Robert A (Chief Financial Officer) Option Ex 3,147 3.78 11,905
2010-01-04 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 4,223 3.78 15,975
2009-10-16 Maddon Paul J (Chief Executive Officer/CSO) Buy 18,500 4.88 90,243
2009-10-01 Baker Mark Robert (General Counsel) Option Ex 3,999 4.26 17,031
2009-10-01 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,666 4.26 11,354
2009-10-01 Olson William C (VP, Research & Development) Option Ex 2,533 4.26 10,788
2009-10-01 Mckinney Robert A (Chief Financial Officer) Option Ex 2,666 4.26 11,354
2009-10-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 3,578 4.26 15,238
2009-07-01 Baker Mark Robert (General Counsel) Option Ex 13,207 5.33 70,393
2009-07-01 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 7,738 5.33 41,243
2009-07-01 Olson William C (VP, Research & Development) Option Ex 6,461 5.33 34,437
2009-07-01 Mckinney Robert A (Chief Financial Officer) Option Ex 7,738 5.33 41,243
2009-07-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 8,210 5.33 43,759
2009-06-23 Boyd Thomas A (Sr. VP, Product Dev.) Sale 2,000 4.73 9,468
2009-06-23 Olson William C (VP, Research & Development) Sale 2,500 4.73 11,815
2009-06-19 Mckinney Robert A (Chief Financial Officer) Sale 5,000 5.25 26,265
2009-04-01 Baker Mark Robert (General Counsel) Option Ex 3,180 5.65 17,967
2009-04-01 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,120 5.65 11,978
2009-04-01 Olson William C (VP, Research & Development) Option Ex 2,014 5.65 11,379
2009-04-01 Mckinney Robert A (Chief Financial Officer) Option Ex 2,120 5.65 11,978
2009-04-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 2,845 5.65 16,074
2009-01-02 Baker Mark Robert (General Counsel) Option Ex 2,033 9.13 18,561
2009-01-02 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 1,355 9.13 12,371
2009-01-02 Olson William C (VP, Research & Development) Option Ex 1,287 9.13 11,750
2009-01-02 Mckinney Robert A (Chief Financial Officer) Option Ex 1,355 9.13 12,371
2009-01-02 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,819 9.13 16,607
2008-10-23 Jacobson Paul F (Director) Sale 27,000 9.05 244,458
2008-10-22 Jacobson Paul F (Director) Sale 35,500 9.38 333,167
2008-10-01 Baker Mark Robert (General Counsel) Option Ex 4,786 6.53 31,252
2008-10-01 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 8,768 6.53 57,254
2008-10-01 Olson William C (VP, Research & Development) Option Ex 2,968 6.53 19,380
2008-10-01 Mckinney Robert A (Chief Financial Officer) Option Ex 3,638 6.53 23,756
2008-10-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 4,882 6.53 31,878
2008-09-03 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 15.00 15,000
2008-09-03 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,000 12.29 12,290
2008-08-28 Briner Kurt W (Director) Option Ex 50,000 9.62 481,250
2008-08-01 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 16.46 16,465
2008-08-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,000 12.29 12,290
2008-07-15 Jacobson Paul F (Director) Sale 10,000 16.04 160,350
2008-07-15 Jacobson Paul F (Director) Option Ex 10,000 6.88 68,820
2008-07-01 Baker Mark Robert (General Counsel) Option Ex 4,865 13.64 66,358
2008-07-01 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,921 13.64 39,842
2008-07-01 Olson William C (VP, Research & Development) Option Ex 2,296 13.64 31,317
2008-07-01 Mckinney Robert A (Chief Financial Officer) Option Ex 2,921 13.64 39,842
2008-07-01 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 15.59 15,592
2008-07-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 4,037 12.96 52,339
2008-06-02 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 16.40 16,397
2008-06-02 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,000 12.29 12,290
2008-05-27 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 15.00 15,000
2008-05-27 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,000 12.29 12,290
2008-05-14 Dalton Mark F (Director) Option Ex 7,500 5.36 40,222
2008-04-25 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 15.00 15,000
2008-04-25 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,000 12.29 12,290
2008-04-01 Baker Mark Robert (General Counsel) Option Ex 2,533 6.52 16,515
2008-04-01 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 1,914 6.52 12,479
2008-04-01 Kremer Alton B (VP, Clinical Research) Option Ex 3,153 6.52 20,557
2008-04-01 Olson William C (VP, Research & Development) Option Ex 1,576 6.52 10,275
2008-04-01 Mckinney Robert A (Chief Financial Officer) Option Ex 1,914 6.52 12,479
2008-04-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 2,702 6.52 17,617
2008-03-28 Scheinberg David A (Director) Option Ex 7,500 4.66 34,957
2008-03-03 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 15.30 15,300
2008-03-03 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,000 12.29 12,290
2008-02-01 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 16.44 16,440
2008-02-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,000 12.29 12,290
2008-01-02 Baker Mark Robert (General Counsel) Option Ex 916 15.33 14,042
2008-01-02 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 692 15.33 10,608
2008-01-02 Kremer Alton B (VP, Clinical Research) Option Ex 1,139 15.36 17,495
2008-01-02 Olson William C (VP, Research & Development) Option Ex 570 15.33 8,738
2008-01-02 Mckinney Robert A (Chief Financial Officer) Option Ex 692 15.33 10,608
2008-01-02 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 18.12 18,120
2008-01-02 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,977 13.81 27,302
2007-12-06 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 20.00 20,000
2007-12-06 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,000 13.75 13,750
2007-12-03 Olson William C (VP, Research & Development) Sale 4,000 19.03 76,112
2007-12-03 Olson William C (VP, Research & Development) Option Ex 4,000 4.00 16,000
2007-12-03 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 19.24 19,239
2007-12-03 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,000 12.29 12,290
2007-10-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 15,000 23.49 352,380
2007-10-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 15,000 5.33 79,950
2007-10-01 Baker Mark Robert (General Counsel) Option Ex 1,496 19.03 28,468
2007-10-01 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 4,058 19.03 77,222
2007-10-01 Kremer Alton B (VP, Clinical Research) Option Ex 4,656 19.03 88,602
2007-10-01 Olson William C (VP, Research & Development) Option Ex 932 19.03 17,734
2007-10-01 Mckinney Robert A (Chief Financial Officer) Option Ex 1,130 19.03 21,502
2007-10-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 22.03 264,312
2007-10-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 13,995 12.18 170,459
2007-10-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,596 19.03 30,370
2007-09-17 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 23.39 280,728
2007-09-17 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-09-04 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 23.77 285,180
2007-09-04 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-08-15 Boyd Thomas A (Sr. VP, Product Dev.) Sale 2,000 22.88 45,766
2007-08-15 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,000 15.41 30,814
2007-08-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 23.16 277,860
2007-08-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-08-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 21.23 254,784
2007-08-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-07-16 Boyd Thomas A (Sr. VP, Product Dev.) Sale 2,000 21.51 43,018
2007-07-16 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,000 15.41 30,814
2007-07-16 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 21.46 257,472
2007-07-16 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-07-02 Baker Mark Robert (General Counsel) Option Ex 3,451 18.71 64,568
2007-07-02 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 545 18.71 10,196
2007-07-02 Kremer Alton B (VP, Clinical Research) Option Ex 852 18.71 15,940
2007-07-02 Olson William C (VP, Research & Development) Option Ex 1,546 18.71 28,925
2007-07-02 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 21.68 260,111
2007-07-02 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 13,986 12.02 168,111
2007-07-02 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 2,156 18.71 40,338
2007-06-15 Boyd Thomas A (Sr. VP, Product Dev.) Sale 2,000 22.03 44,054
2007-06-15 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,000 15.41 30,814
2007-06-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 21.75 261,012
2007-06-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-05-15 Boyd Thomas A (Sr. VP, Product Dev.) Sale 2,000 21.90 43,804
2007-05-15 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,000 15.41 30,814
2007-05-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 21.90 262,800
2007-05-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-05-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 25.61 307,356
2007-05-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-04-16 Boyd Thomas A (Sr. VP, Product Dev.) Sale 4,000 26.94 107,748
2007-04-16 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 4,000 15.41 61,628
2007-04-16 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 26.80 321,588
2007-04-16 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-04-02 Baker Mark Robert (General Counsel) Option Ex 621 20.13 12,500
2007-04-02 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,018 20.13 40,622
2007-04-02 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 23.85 286,152
2007-04-02 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 13,754 12.73 175,088
2007-03-15 Boyd Thomas A (Sr. VP, Product Dev.) Sale 2,000 22.78 45,568
2007-03-15 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,000 15.41 30,814
2007-03-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 22.95 275,424
2007-03-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-03-01 Scheinberg David A (Director) Sale 10,000 25.99 259,890
2007-03-01 Scheinberg David A (Director) Option Ex 10,000 4.00 40,000
2007-03-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 26.49 317,832
2007-03-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-02-15 Boyd Thomas A (Sr. VP, Product Dev.) Sale 4,000 29.97 119,896
2007-02-15 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 4,000 17.19 68,760
2007-02-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 29.89 358,716
2007-02-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-02-12 Mckinney Robert A (Chief Financial Officer) Sale 4,000 29.48 117,908
2007-02-12 Mckinney Robert A (Chief Financial Officer) Option Ex 4,000 4.00 16,000
2007-02-02 Scheinberg David A (Director) Sale 30,000 30.09 902,850
2007-02-02 Scheinberg David A (Director) Option Ex 30,000 4.00 120,000
2007-02-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 29.89 358,632
2007-02-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-01-29 Mckinney Robert A (Chief Financial Officer) Sale 4,000 29.72 118,872
Go to page:  1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of PGNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Progenics Pharmaceuticals Inc (symbol PGNX, CIK number 835887) see the Securities and Exchange Commission (SEC) website.